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Table 2
Partial Spearman's Rank Correlations between structural hip OA parameters and VPT
scores after adjusting for age.
Scanned Contralateral
MTP MM MFC RH MTP MM MFC RH
Cartilage Lesions r .277 -.005 .119 .169 .194 .132 .073 .071
P value .092 .975 .475 .310 .244 .430 .665 .672
BMEL r .139 -.056 .070 .319 .217 .094 .151 .185
P value .405 .738 .676 .051 .190 .575 .366 .265
Subchondral Cyst r .367 .020 .034 .386 .107 .265 .024 .260
P value .023 .906 .837 .017 .522 .108 .885 .115
Labral Tear r .228 .199 .087 -.103 .015 .359 -.157 -.042
P value .168 .231 .602 .537 .929 .027 .345 .804
KL r .282 .135 .057 .295 .362 .199 .156 .106
P value .087 .418 .732 .073 .026 .231 .348 .527
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evaluated.
Methods: The data for this study are from participants recruited for a
longitudinal observational study on hip OA. Subjects were recruited
from the community using ﬂyers and advertisements. The inclusion
criteria for ROA patients (þRHOA) were Kellgren-Lawrence (KL) grade
of 2 or 3 at the hip on weight-bearing anterior-posterior radiographs.
The side with greater KL grade was selected as the “index hip”. The
control subjects (-RHOA) had a radiographic KL grade of 0 or 1 at both
hips, and were without history of diagnosed OA or previous hip injuries.
General exclusion criteria for recruitment into the study for all subjects
were any contra-indications to MR imaging, KL grade of 4, a total joint
replacement of any lower extremity joint, previous hip trauma, pain at
any other lower extremity joint, radiographic evidence of any knee or
ankle joint OA, systemic inﬂammatory arthritis or any other spine or
lower extremity condition that would affect their ability to complete
the study procedures. Vibratory perception threshold (VPT) testing was
added to the study protocol 18 months after study initiation and hence
data are available from a subset of the original study participants. VPT
testing was performed using a commercial biothesiometer (Bio-medical
Instrument Company, Newbury, OH, USA). The anatomic sites evaluated
for VPT included bilateral 1st Metatarsophalangeal joint (MTP), medial
malleolus (MM), medial femoral condyle (MF), and radial head (RH).
Each familiarization with the testing method, each subject performed
three trials at each anatomical site, and the mean of last 2 trials used in
the analyses. Additional outcomes included semi-quantitative mor-
phological grading of hip cartilage and labral lesions from 3.0 Tesla MR
images using the Scoring of Hip Osteoarthritis with MRI (SHOMRI).
Patient-reported outcomes included the Hip Osteoarthritis Outcome
Score (HOOS), and physical function was evaluated with the 6 minute
walk test (6MWT), and the Timed-up and Go Test (TUG). Multivariate
ANOVA (adjusted for age) was used to evaluate the differences in VPT
scores between the groups. Non-parametric partial correlations adjus-
ted for age were used to evaluate the association of KL and clinical MRI
scores with VPT.
Results: VPT data were available from a subset of the original study
participants in the þRHOA (n ¼ 12, Age ¼ 54.3±13.6 years; BMI ¼
23.5±2.9 kg/m2; 9M:3W) and -RHOA groups (n¼27; Age ¼ 41.5±12.2
years; BMI ¼ 23.3±3.3 kg/m2; 13M:14W). The þRHOA group was older
(P ¼ 0.006) hence all analyses were adjusted for age. There were no
signiﬁcant differences between the groups for HOOS, 6MWT, or TUG.
Mean HOOS scores for both groups were > 85%. After adjusting for age,
there were no differences in VPT at any site between the subjects with
(KL >1) and without (KL <2) radiographic hip OA (Table 1).However, after adjusting for age, subjects with KL¼ 3 (n¼ 5) had higher
VPT scores compared to subjects with lower KL grades at most sites.
Higher VPT scores were associated with higher radiographic KL and
morphological MRI scores. However this association was not signiﬁcant
after adjusting for age and p-values for multiple comparisons (Table 2).Conclusions: In this small substudy, vibratory deﬁcits were not differ-
ent between subjects with and without radiographic hip OA. However,
we did observe modest difference in vibratory sensation in subjects
with both age and more advanced radiographic hip OA.
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ASSOCIATION BETWEEN POPLITEAL ARTERY WALL THICKNESS AND
KNEE CARTILAGE VOLUME LOSS IN COMMUNITY-BASED MIDDLE-
AGED WOMEN WITHOUT CLINICAL KNEE DISEASE: A PROSPECTIVE
COHORT STUDY
Y. Wang, C. Dawson, S. Davis, R. Bell, F. Hanna, J. Fairley, F. Cicuttini.
Monash Univ., Melbourne, Australia
Purpose: Increasing evidence suggests a role of vascular pathology in
the pathogenesis of osteoarthritis. This study examined the association
between popliteal artery wall thickness, a surrogate marker of car-
diovascular disease, and knee cartilage volume loss in an asymptomatic
cohort of women.
Methods: 170womenwith no signiﬁcant knee pain, injury, or history of
clinical knee disease underwent knee magnetic resonance imaging at
baseline and 2 years later. Popliteal artery wall thickness and knee
cartilage volume and bone areawere assessed using validatedmethods.
Results: 142 women (83.5%) completed 2-year follow-up. After
adjusting for age, body mass index and tibial bone area, increased
popliteal artery wall thickness was associated with increased rate of
medial tibial cartilage volume loss. With increasing tertiles of popliteal
artery wall thickness, the mean (standard error) of annual medial tibial
cartilage volume loss was 1.62 (0.45)%, 2.18 (0.43)%, and 2.98 (0.48)%,
respectively, p for trend¼ 0.04. No signiﬁcant association was observed
in lateral tibial cartilage.
Conclusions: In community-based women increased popliteal artery
wall thickness is associated with adverse changes in knee cartilage as
evidenced by increased rate of cartilage volume loss over 2 years. These
ﬁndings suggest an association between vascular pathology and early
knee structural changes, supporting the hypothesis that there is a
vascular contribution to the development of knee osteoarthritis.
Although needing to be conﬁrmed in other studies, these results sug-
gest that targeting vascular pathology may provide a potential target for
the prevention and early treatment of knee osteoarthritis in women.
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PAIN DISTRIBUTION IN PRIMARY CARE PATIENTS WITH HIP
OSTEOARTHRITIS e A DESCRIPTIVE STUDY
E. Poulsen y,z, S. Overgaard x,y, J.T. Vestergaard z, H.W. Christensen z,
J. Hartvigsen y,z. yUniv. of Southern Denmark, Odense, Denmark; zNordic
Inst. of Chiro. and Clin. Biomech., Odense, Denmark; xOdense Univ. Hosp.,
Odense, Denmark
Purpose: To describe pain location and pain distribution in a cohort of
primary care patients with unilateral hip osteoarthritis (OA).
Abstracts / Osteoarthritis and Cartilage 23 (2015) A82eA416 A335Methods: Primary care patients with unilateral clinical and radio-
graphic hip OA, participating in a randomized clinical trial, recorded at
baseline pain intensity using an 11-box numeric rating scale, pain
duration in months and the distribution of hip pain using a manikin
displaying three separate views: front, back and lateral. Pain drawings
were analysed using a template to determine pain locations and dis-
tribution of pain. Drawings were subsequently digitally processed to
produce a composite image using colours to illustrate frequency.
Results: A total of 108/109 (99%) patients completed pain drawings
according to instructions. One drawing consisted of a single line but the
identiﬁed areas were included in the analyses of pain location and the
composite image. The mean age was 65 (SD 9), 44% were females, the
right/left hip ratio was 66/43 respectively, the mean pain duration was
32 months (SD 36, range 4e300), and mean pain intensity was 5.4 (SD
2.0). A total of 77% had marked the area of the greater trochanter, 53%
the groin, 42% the anterior/lateral thigh, 38% the buttock, 17% the knee
and 15% the lower leg. Less than 20% of the patients reported pain in
only one area, most commonly the greater trochanter area (16%).
Between 1-2% of the patients reported pain only at the groin, buttock or
anterior/lateral thigh. No patients marked pain exclusively in the areas
of the knee, posterior thigh or lower leg. The composite images of the
cumulated pain drawings in the three planes are illustrated in Figure 1.
Conclusions: To our knowledge, this is the ﬁrst study describing pain
location and distribution in a cohort of patients presenting to primary
care with hip pain and unilateral hip OA. In descending order, the most
common pain locations are the greater trochanter, groin, thigh and
buttock areas. No patients with hip OA reported pain exclusively in the
knee or to the lower leg areas. When adult patients in primary care
present with pain in the greater trochanter, groin, anterior lateral thigh
or buttock areas, the clinician as a minimum should include a physical
examination of the hip joint.
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CONCERNS IMPORTANT TO ELDERLY PATIENTS WITH HAND
OSTEOARTHRITIS: A QUALITATIVE MULTI-ETHNIC ASIAN STUDY
Y.Y. Leung y, W. Li z, J. Thumboo y. y Singapore Gen. Hosp., Singapore,
Singapore; zDuke-NUS Graduate Med. Sch. Singapore, Singapore,
Singapore
Purpose: Hand osteoarthritis (HOA) is common but little is known
about how to measure the impact on disability and quality of life (QoL)
among patients with HOA. None of the existing HOA speciﬁc instru-
ments was patients-derived. With the ageing population, there is a
need to develop instruments in patients' perspective for measuring
disability and QoL for use in future drug trials. We aim to identify
important concerns among patients suffering from symptomatic HOA
in Singapore. It is the ﬁrst study with participation of patients from the
Asian socio-cultural context.
Methods: A qualitative study using a focus group technique was per-
formed. Patients with symptomatic HOA according to American college
of Rheumatology Classiﬁcation criteria were recruited from outpatient
clinic of a tertiary centre. Focus groups were conducted as stratiﬁed by
gender, ethnicity and language. All discussions were audio-taped and
analyzed in an inductive approach. Areas of concern important to study
participants were then compared to the following commonly used HOA
speciﬁc instruments: FIHOA, SACRAH, AUSCAN and HAQ.
Results: Twenty-six patients [23 women, 3 men; 23 Chinese and 3
Malay; mean (SD) age 62.9 (7.5) years] participated in seven focusgroups. Two and ﬁve focus groups were conducted in Chinese and
English respectively. The qualitative analysis revealed detailed
descriptions of pain sensations at different qualities, and its relation to
activity and environment, none of which were fully represented in the
existing instruments. Psychological consequences, aesthetic concerns,
participation in leisure activities, participation in family roles and social
activities are important concerns from the focus groups which were not
covered by the existing instruments. Important QoL concerns that
impact on the Asian style of living including eating, cooking and praying
was revealed. Impact on work productivity by HOA was also revealed.
Out of the 59 concerns among patients with HOA, only 16 concerns
(27%) were covered with the existing instruments.
Conclusions: The concerns important to HOA patients are not fully
represented in the most commonly used instruments, which were not
patient-derived. This qualitative study helps to reﬁne the concerns of
people with HOA in patients' perspectives. It gives information on
selection of domains for the development of instrument that measure
QoL of HOA patients.
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THE ROLE OF сYTOKINES IN PATIENTS WITH OSTEOARTHRITIS AND
TYPE 2 DIABETES MELLITUS
M. Oliinyk. Kharkov Natl. Med. Univ., Kharkov, Ukraine
Purpose: to investigate inﬂuence of concentration in plasma tumor
necrosis factor-a (TNF-a), interleukin-1b (IL-1b) on articular syndrome
and parameters of carbohydrate metabolism in patients with osteo-
arthritis (OA) and type 2 diabetes mellitus (T2DM).
Methods: The study was performed on 65 patients (29 males), aged
57.9 ± 3.2 with combination OA and T2DM in Regional Hospital of
Kharkov. Baseline characteristics of patients included history of OA (7.1
± 2.3 years), T2DM (8.1 ± 2.5 years). All patients were divided into 2
groups: group 1 (n¼ 30) ewith combined course of OA and T2DMwith
normal body weight, group 2 (n ¼ 35) e with combined course of OA
and T2DM with obesity (BMI 30 kg/m2). The survey plan included:
anthropometric data, indices of carbohydrate exchange (insulin, glu-
cose, HbA1C, HOMA-IR) and level of C-reactive protein (CRP). The level
of HbA1C was <7.5% in all patients. The level of TNF-a and IL-1b was
determined by ELISA. All patients were made X-ray examination of
knees.
Results: Signiﬁcant correlation between TNF-a and CRP was deter-
mined in 1st group (r¼0.59; р<0.05) and 2nd group (r¼0.72; р<0.05),
also correlation between IL-1b and CRP was determined in 1st group
(r¼0.61; р<0.05) and 2nd group (r¼0.78; р<0.05). Among the 1st group
of patients the level of insulin resistance was correlated with TNF-a
(r¼0.36; р<0.05) and IL-1b (r¼0.42; р<0.05). More signiﬁcant correla-
tion between TNF-a and glucose (r¼0.44; р<0.05), HbA1C (r¼0.54;
р<0.05), insulin resistance (r¼0.74; р<0.05), HOMAIR (r¼0.63; р<0.05)
and between IL-1b and glucose (r¼0.42; р<0.05), HbA1C (r¼0.40;
р<0.05), insulin resistance (r¼0.52; р<0.05), HOMAIR (r¼0.50; р<0.05)
was determined in 2nd groupwith comorbid pathology and obesity. We
noticed, the degree of X-ray changes (by Kellgren-Lawrence) were more
in 2nd group in compare with the 1st group.
Conclusions: Signiﬁcant correlation between TNF-a, IL-1b and CRP,
glucose, НbА1, insulin resistance, HOMA-IR in group of patients with
comorbid pathology and obesity means, that obesity is important factor
of pathogenesis relationship immune and metabolic processes in
patients with OA and T2DM.
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SOLUMATRIX DICLOFENAC SAFETY IN OLDER PATIENTS WITH
OSTEOARTHRITIS PAIN
R.D. Altman y, M. Hochberg z, A. Gibofsky x, P. Tenzer k, C.L. Young ¶.
yDavid Geffen Sch. of Med., Univ. of California Los Angeles, Los Angeles,
CA, USA; zUniv. of Maryland Sch. of Med., Baltimore, MD, USA; xHosp.
for Special Surgery, New York, NY, USA; kUniv. of Miami Miller Sch. of
Med., Miami, FL, USA; ¶ Iroko Pharmaceuticals, Philadelphia, PA, USA
Purpose: SoluMatrix® diclofenac is a low-dose nonsteroidal anti-
inﬂammatory drug (NSAID) treatment option developed using Sol-
uMatrix Fine Particle Technology™ to provide effective analgesia at
lower doses than commercially available diclofenac drug products.
SoluMatrix diclofenac was developed to address concerns regarding the
risks for dose-related adverse events (AEs) that have led health
